For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Publications

Found 6 results
Author Title [ Type(Desc)] Year
Filters: Author is Harrop, James S  [Clear All Filters]
Journal Article
Ghobrial GM, Harrop JS, Sasso RC, Tannoury CA, Tannoury T, Smith ZA, Hsu WK, Arnold PM, Fehlings MG, Mroz TE et al..  2017.  Anterior Cervical Infection: Presentation and Incidence of an Uncommon Postoperative Complication.. Global Spine J. 7(1 Suppl):12S-16S.
Fehlings MG, Tetreault LA, K Riew D, Middleton JW, Aarabi B, Arnold PM, Brodke DS, Burns AS, Carette S, Chen R et al..  2017.  A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.. Global Spine J. 7(3 Suppl):70S-83S.
Ghogawala Z, Terrin N, Dunbar MR, Breeze JL, Freund KM, Kanter AS, Mummaneni PV, Bisson EF, Barker FG, J Schwartz S et al..  2021.  Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy: A Randomized Clinical Trial.. JAMA. 325(10):942-951.
Mikhail C, Pennington Z, Arnold PM, Brodke DS, Chapman JR, Chutkan N, Daubs MD, DeVine JG, Fehlings MG, Gelb DE et al..  2020.  Minimizing Blood Loss in Spine Surgery.. Global Spine J. 10(1 Suppl):71S-83S.
Fehlings MG, Badhiwala JH, Ahn H, H Farhadi F, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, W Jacobs B, K Riew D et al..  2021.  Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.. Lancet Neurol. 20(2):98-106.
Rymarczuk GN, Harrop JS, Hilis A, Härtl R.  2017.  Should Expandable TLIF Cages be Used Routinely to Increase Lordosis? Clin Spine Surg. 30(2):47-49.